DB2114951: A randomized, multi-center, double-blind, double-dummy, parallel group study to evaluate the efficacy umeclidinium/vilanterol compared with fluticasone propionate/salmeterol over 12 weeks in subjects with COPD

Authors
Category Primary study
Registry of TrialsGSK Study Register
Year 2013
This article has no abstract
Epistemonikos ID: 5afcb6277f1c7d28e4b3baab67f5b2e929b3970f
First added on: Sep 04, 2019